Ib. Salusky et al., BIOCHEMICAL MARKERS OF RENAL OSTEODYSTROPHY IN PEDIATRIC-PATIENTS UNDERGOING CAPD CCPD, Kidney international, 45(1), 1994, pp. 253-258
Serum intact PTH [1-84] levels were evaluated as a potential non-invas
ive method for the diagnosis of renal osteodystrophy in children treat
ed with CAPD/CCPD. Sixty-eight bone biopsy samples were obtained from
55 patients, aged 13 +/- 5 (X +/- SD) years, undergoing CAPD/CCPD for
29 +/- 13 months; osteitis fibrosa was present in 34 cases, mild lesio
ns of secondary hyperparathyroidism in six, 15 had adynamic lesions, a
nd 13 were classified as normal histology. Serum calcium levels were h
igher in patients with adynamic bone or normal bone histology than in
those with secondary hyperparathyroidism, whereas serum phosphorus, al
kaline phosphatase and PTH levels were greater in patients with osteit
is fibrosa. The combination of a serum PTH level >200 pg/ml and a seru
m calcium value < 10 mg/dl was 85% sensitive and 100%, specific for id
entifying patients with high-turnover lesions of bone. Serum PTH value
s <200 pg/ml were 100% sensitive but only 79% specific for patients wi
th adynamic bone; specificity increased to 92%, however, using the com
bined criteria of a PTH level <150 pg/ml and a serum calcium level >10
mg/dl. Higher serum calcium levels and serum PTH values within or bel
ow the normal range characterize patients with the adynamic lesion of
renal osteodystrophy. Serum PTH levels of approximately 200 pg/ml are
useful for distinguishing patients with low-turnover lesions of renal
osteodystrophy from those with secondary hyperparathyroidism.